athenahealth Initiates Process to Explore Strategic Alternatives, Including Search for New Chief Executive Officer

Mr. Immelt was Chairman and CEO of GE from 2001 to 2017.  During that time he focused on growth and creating new disruptive technologies.  GE became a more global, technology leader with record market share in essential industries.  He was also one of the first CEOs to recognize great industrial companies must be digital leaders.

Mr. Immelt is one of the most respected leaders in healthcare.  He helped grow GE’s Healthcare business from a $3 billion enterprise to a $20 billion respected innovator with unique assets and capabilities.  GE Healthcare diversified its portfolio from imaging to life science and digital services, building leadership positions by delivering valuable solutions to providers and patients.  Mr. Immelt also brings a deep understanding of system economics and patient outcomes given GE’s position as a larger payer of healthcare benefits.

Mr. Immelt earned a B.A. degree in applied mathematics from Dartmouth College in 1978 and an M.B.A. from Harvard University in 1982.

About Amy Abernethy, M.D., Ph.D.
Amy Abernethy, M.D., Ph.D. has served as a member of the athenahealth Board of Directors since October 2013.

Since July 2014, Dr. Abernethy has served as chief medical officer, chief scientific officer and senior vice president of oncology at Flatiron Health, Inc., a healthcare technology company that is a member of the Roche Group.  Before joining Flatiron, she was a professor of medicine in the Duke University School of Medicine from November 2008 to July 2015 and ran the Center for Learning Health Care in the Duke Clinical Research Institute from March 2012 to July 2015.  She was also director of the Duke Cancer Care Research Program in the Duke Cancer Institute between 2008 and 2015.  She also holds the title of adjunct professor of medicine in the Duke University School of Medicine, and previously held a number of progressive faculty and clinical roles at Duke University and Flinders University of South Australia.

Dr. Abernethy received her B.A. in biochemistry from the University of Pennsylvania and her M.D. from the Duke University School of Medicine.  She also received a Ph.D. from Flinders University of South Australia.

1 2 3 4 5 6 7 8 9 10